| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/11/2005 | WO2005044305A3 Methods of therapy for solid tumors expressing the cd40 cell-surface antigen |
| 08/11/2005 | WO2005041877A9 Method of inhibiting rejection following organ transplantation |
| 08/11/2005 | WO2005033142A3 Anti-nik antibodies and uses thereof |
| 08/11/2005 | WO2005019457A3 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY |
| 08/11/2005 | WO2005013800A3 Elevated hedgehog pathway activity in digestive system tumors, and methods of treating digestive system tumors having elevated hedgehog pathway activity |
| 08/11/2005 | WO2005001053A3 Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular antagonist |
| 08/11/2005 | WO2005000899A3 Modified binding molecules comprising connecting peptides |
| 08/11/2005 | WO2004099376A3 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity |
| 08/11/2005 | WO2004070025A3 Novel goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders |
| 08/11/2005 | WO2004066917A3 Tandem analyses of noncovalently driven effectors for modulatory mapping of activities of protein sites |
| 08/11/2005 | WO2004050842A3 Atm kinase compositions and methods |
| 08/11/2005 | WO2004030522A3 Diagnosis and monitoring of diseases |
| 08/11/2005 | WO2004004662A3 Compositions and methods for the diagnosis and treatment of tumor |
| 08/11/2005 | WO2003077836A3 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 08/11/2005 | WO2003075846A3 Uses of monoclonal antibody 8h9 |
| 08/11/2005 | WO2003062446A3 Mrp9 and its use detecting and treating cancer |
| 08/11/2005 | US20050177884 Chimeric nonhuman animal |
| 08/11/2005 | US20050177881 Using presence of allelic mutations in lysosomal acid lipase (LIPA) and cholesterol 25-hydroxylase (CH25H) as diagnostic indicator of nervous system disorders |
| 08/11/2005 | US20050177879 Using nuclear transplantation to generate animal which express human growth hormone in mammary glands; bioreactors |
| 08/11/2005 | US20050177878 Process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby |
| 08/11/2005 | US20050176945 Cloning and characterization of slc26a7 and slc26a9 anion exchangers |
| 08/11/2005 | US20050176944 Intracellular signaling polypeptide for identifying modulator for prevention and treatment cell proliferative, endocrine, autoimmune/inflammatory, neurological, gastrointestinal, reproductive, developmental, and vesicle trafficking disorders |
| 08/11/2005 | US20050176935 Dna dependent protein kinase catalytic subunit phosphorylation sites and antibodies thereto |
| 08/11/2005 | US20050176934 Antibody combination useful for tumor therapy |
| 08/11/2005 | US20050176933 Nucleotide sequences coding hepatocyte specific immunoglobulin for use in prevention and treatment of cell proliferative disorders; immunotherapy; antitumor agents |
| 08/11/2005 | US20050176930 Nucleotide sequences coding tumor associated antigen for use in diagnosis, prevention and treatment of cell proliferative disorders; mimetics; antitumor agents |
| 08/11/2005 | US20050176927 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; diagnosis |
| 08/11/2005 | US20050176660 Use of specific antisense-based constructs and peptide-specific polyclonal and monoclonal antibodies in leukemia, acute or chronic tissue damages, HIV-related damage of brain or other tissues, skeletal muscle disorders, transplantation rejection; Parkinson's disease; amyotrophic lateral sclerosis |
| 08/11/2005 | US20050176634 substitution or the elimination ofcysteine residue (Cys) in the C-terminal portion of the wild type protein polypeptide sequence; prevents multimerisation of monomeric form but does not affect dimerisation; storage stability; treatment of ischemia, scleroderma, skin ulcer, aging, burn, wound; cosmetic |
| 08/11/2005 | US20050176633 low-molecular weight compounds, peptides and proteins, particularly antibodies or antibody fragments; drug screening; increased G-protein mediated signal transduction |
| 08/11/2005 | US20050176122 Isolation of proteins |
| 08/11/2005 | US20050176109 Protein A chromatography; desorption via arginine and/or derivative thereof |
| 08/11/2005 | US20050176108 Physiologically active polypeptide conjugate having prolonged in vivo half-life |
| 08/11/2005 | US20050176104 Using overexpression of nucleotide sequences coding tumor associated antigen as diagnostic/prognostic tool in detection of cancer |
| 08/11/2005 | US20050176102 Totipotent hematopoietic stem cell receptors and their ligands |
| 08/11/2005 | US20050176099 Plasmid system for multigene expression |
| 08/11/2005 | US20050176094 Polypeptide having immunomodulatory activity, antiviral activity, and antitumor activity; polynucleotides, expression vectors , probes and antibodies; predicting responsiveness to treatment with interferon- alpha and other interferons which act at the Type 1 interferon receptor |
| 08/11/2005 | US20050176081 Using protrein oxidation as diagnostic tool in detection of arthritic, cell proliferative, nervous system and autoimmue disorders |
| 08/11/2005 | US20050176080 quantitative analysis of tacrolimus |
| 08/11/2005 | US20050176077 Using urease as tool in identifying modulators of bacterial propagation; enzyme inhibitors |
| 08/11/2005 | US20050176075 Mdm2 splice variants |
| 08/11/2005 | US20050176065 Biarsenical molecules label tetracycsteine polypeptides; orthogonal labelling for observing conformational changes; solid phase synthesis; kits |
| 08/11/2005 | US20050176046 Compositions and methods for the diagnosis and treatment of tumors |
| 08/11/2005 | US20050176044 Polynucleotides and polypeptides encoding receptors |
| 08/11/2005 | US20050176041 Using membrane proteins as tool in diagnosis, prevention and treatment of cell proliferative disorders |
| 08/11/2005 | US20050176039 Macrophage migration inhibitory factor (MIF) as marker for urological inflammatory disease |
| 08/11/2005 | US20050176028 CD3 ligand for use in diagnosis, prevention and treatment of infection, allergies, cell proliferative, autoimmue, viral and host vs graft disorders |
| 08/11/2005 | US20050176022 Vertebrate telomerase genes and proteins and uses thereof |
| 08/11/2005 | US20050176020 I-CAM related protein |
| 08/11/2005 | US20050175998 Immunoconjugate for stimulating myelinogenesis, differentiation of oligodendroglial precursor cells, tyrosine kinase, the expression of myelin basic protein and detecting myelinogenetic oligodendroglias |
| 08/11/2005 | US20050175986 Human monoclonal antibody |
| 08/11/2005 | US20050175633 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a PRRSV and a method of detecting a PRRSV |
| 08/11/2005 | US20050175631 Hiv vaccine and method of use |
| 08/11/2005 | US20050175626 Determining susceptibility; screening for clearance of deposition materials; developing antibodies |
| 08/11/2005 | US20050175619 Methods of producing antibody conjugates |
| 08/11/2005 | US20050175618 Delivery of agents directly to tumor cell cytoplasm |
| 08/11/2005 | US20050175616 PCDGF receptor antibodies and methods of use thereof |
| 08/11/2005 | US20050175614 Binding domain-immunoglobulin fusion proteins |
| 08/11/2005 | US20050175613 Compositions and methods for treating hyperimmune response in the eye |
| 08/11/2005 | US20050175611 Storage stability, heat resistance; such as cetuximab combined with glycine and polyoxyethylene sorbitan monooleate in aqueous pH 5.5 citrate buffer |
| 08/11/2005 | US20050175609 Placental growth factor as a target for the treatment of osteoporosis |
| 08/11/2005 | US20050175608 Remedies for arthritis |
| 08/11/2005 | US20050175606 Cyclic single-chain trispecific antibody |
| 08/11/2005 | US20050175604 Administering a plurality of two autoimmune inhibitors selected from the group consisting of an antibody to alpha interferon, an antibody to gamma interferon, and an antibody to tumor necrosis factor alpha |
| 08/11/2005 | US20050175602 Mixing protein with a saccharide compound in a liquid suspension and then drying to produce a solid that contains the protein and the saccharide |
| 08/11/2005 | US20050175583 Making vector compositions that mimic the functionality of components of the immune system especially antigen-presenting cell (APC) element of the immune synapse; vaccination |
| 08/11/2005 | US20050175582 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 08/11/2005 | DE10306992A1 Verfahren zur quantitativen Messung von Liganden in der Probe gelöster Bindungsproteine A method for quantitative measurement of ligand binding proteins in the sample dissolved |
| 08/11/2005 | CA2556849A1 Inhibition of bright function as a treatment for excessive immunoglobulin production |
| 08/11/2005 | CA2554846A1 Method of quickly measuring factor causing early flocculation of yeast |
| 08/11/2005 | CA2554825A1 Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone |
| 08/11/2005 | CA2554753A1 Composition and method for elevating gene transfer efficiency |
| 08/11/2005 | CA2554729A1 Polymer-bound antibody cancer therapeutic agent |
| 08/11/2005 | CA2554623A1 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of colon cancer |
| 08/11/2005 | CA2554599A1 Novel brain natriuretic peptide variants and methods of use thereof |
| 08/11/2005 | CA2554475A1 Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use |
| 08/11/2005 | CA2554440A1 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer |
| 08/11/2005 | CA2554410A1 Biotherapeutics, diagnostics and research reagents |
| 08/11/2005 | CA2553989A1 Production of host cells containing mutiple integrating vectors by serial transduction |
| 08/11/2005 | CA2553187A1 Heterodimeric follicle stimulating hormone-fc (fsh-fc) fusion proteins for the treatment of infertility |
| 08/10/2005 | EP1561816A1 Methods for determining genetic resistance of pigs to diseases caused by rna viruses |
| 08/10/2005 | EP1561814A1 Gene expressed specifically in dopamine-producing neuron precursor cells after termination of division |
| 08/10/2005 | EP1561759A1 Cell death-inducing agent |
| 08/10/2005 | EP1561758A1 Method for isolating and purifying viruses from plant sources |
| 08/10/2005 | EP1561756A1 Method of purifying protein |
| 08/10/2005 | EP1561471A1 Cell growth regulator |
| 08/10/2005 | EP1561117A1 Diagnostic and therapeutic use of arl7 for alzheimer's disease |
| 08/10/2005 | EP1561111A1 Antibodies reactive with beta (1-3) -glucans |
| 08/10/2005 | EP1561107A1 Method for identifying antigen specific b cells |
| 08/10/2005 | EP1560918A2 Compositions and methods for the modulation of viral maturation |
| 08/10/2005 | EP1560853A2 Intracellular antibodies |
| 08/10/2005 | EP1560852A2 Intrabodies againstthe oncogenic form of ras |
| 08/10/2005 | EP1560850A2 Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion |
| 08/10/2005 | EP1560849A1 Growth hormone variations in humans and its uses |
| 08/10/2005 | EP1560848A2 Ptprk immunogenic peptide |
| 08/10/2005 | EP1560847A2 Acetylated hmgb1 protein |
| 08/10/2005 | EP1560597A2 Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same |
| 08/10/2005 | EP1560596A1 Use of multi-specific, non-covalent complexes for targeted delivery of therapeutics |
| 08/10/2005 | EP1560595A2 Fully human antibody fab fragments with human interferon-gamma neutralizing activity |
| 08/10/2005 | EP1560594A1 Immunization of non-human mammals against streptococcus equi |